New Rimantadine-Grindeks already available in chemistry shops!


JSC “Grindeks” informs, that starting from December 10, 2009
Rimantadine-Grindeks 50mg N20 tablets, the antiviral medication effective
against seasonal influenza, are available in chemistry shops of Latvia.
According to the data of World Health Organization, the seasonal influenza in
2010 will become acute earlier than in past years. Rimantadine-Grindeks 50mg
N20 tablets will be first product in the anti-viral product portfolio of the
Company. 

The active substance of Rimantadine-Grindeks is rimantadine hydrochloride and
its commonly used chemical name is rimantadine. For the first time, the
substance was synthesized in Latvian Institute of Organic Synthesis 40 years
ago. 

The price of Rimantadine-Grindeks 50mg N20 in the chemistry shops of Latvia
will be under 5 Lats per pack. 

Chairman of the Board of “Grindeks” Jānis Romanovskis: “As it is well known,
the demand determines the supply; therefore we must offer medications in
response to the society needs. In this case - anti-flu medication is required
and we can be proud, that we are able to provide effective, high quality
product produced according to EU high standard requirements for the fight
against seasonal influenza!” 

“Grindeks” also plans to register and manufacture Rimantadine-Grindeks 100mg.


About “Grindeks”

“Grindeks” is the leading pharmaceutical company in the Baltic States. The main
directions of its operation are research, development, manufacturing and sales
of original products, as well as generics and active pharmaceutical
ingredients. “Grindeks” concern consists of four subsidiary companies in
Latvia, Estonia and Russia; as well as representatives and representative
offices in 14 countries. Products of the company are exported to more than 40
countries and its export comprises more than 96% of the total turnover. The
main markets are the Baltic States, Russia and other CIS countries, as well as
Japan and USA. The shares of JSC “Grindeks” are listed in the Official List of
“NASDAQ OMX Riga”. 


Further information:

Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
E-mail: laila.klavina@grindeks.lv 
Phones: +371 67083370, +371 29256012